and the TDP-43, tau, and FUS proteins, causing
pathological conformation changes and aggregate formation
methods of
pathology detection.
The aim of the study was to evaluate the effectiveness of inflammatory
Bikbov, Mukharram M.,
Kazakbaeva, Gyulli M.,
Holz, Frank G.,
Panda-Jonas, Songhomitra,
Gilemzianova, Leisan I.,
Khakimov, Dinar A.,
Jonas, Jost B. (2023) with
pathological myopia. Methods: The clinical, monocentre, open-label, multiple-dose, phase-1 study included